Sign in
4/A

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001618835-18-000128

Options or other derivatives

  • Chief Financial Officer acquired 103,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

File Justin J. · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-11-28 Grant or award : show line 1 in the form Stock option (right to buy) +103,500 103,500 D
Loading xslF345X03/wf-form4a_154385943828394.xml…